U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    VAV3 vav guanine nucleotide exchange factor 3 [ Homo sapiens (human) ]

    Gene ID: 10451, updated on 14-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability.

    DDX5 promotes esophageal squamous cell carcinoma growth through sustaining VAV3 mRNA stability.
    Shi Y, Wang J, Yuan Q, Chen Y, Zhao M, Li X, Wang Z, Zhou H, Zhu F, Wei B, Jiang Y, Zhao J, Qiao Y, Dong Z, Liu K.

    11/7/2024
    Serum exosome-derived miR-146a-3p promotes macrophage M2 polarization in allergic rhinitis by targeting VAV3 via PI3K/AKT/mTOR pathway.

    Serum exosome-derived miR-146a-3p promotes macrophage M2 polarization in allergic rhinitis by targeting VAV3 via PI3K/AKT/mTOR pathway.
    Xia C, Zhu K, Zhang Y, Chen J, Yu C, Gao T, Zheng G.

    11/2/2023
    VAV3 in human cancers: Mechanism and clinical implication.

    VAV3 in human cancers: Mechanism and clinical implication.
    Al-Hawary SIS, Alsalamy A, Gupta R, Alsaab HO, Hjazi A, Edilboyev U, Ramadan MF, Hussien BM, Ahmed M, Hosseini-Fard SR.

    08/17/2023
    Rs7537605 polymorphism in VAV3 gene and rs28665122 polymorphism in SEPS gene are not associated with Hashimoto's thyroiditis in North-East Algerian population.

    Rs7537605 polymorphism in VAV3 gene and rs28665122 polymorphism in SEPS gene are not associated with Hashimoto's thyroiditis in North-East Algerian population.
    Kherrour W, Benbia S, Hambaba L, Kaličanin D., Free PMC Article

    05/4/2023
    CARD9, VAV3, and infection risk in IgA nephropathy.

    CARD9, VAV3, and infection risk in IgA nephropathy.
    Gleeson PJ, Sokol H, Monteiro RC.

    04/26/2023
    VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem-like cell self-renewal.

    VAV3 regulates glioblastoma cell proliferation, migration, invasion and cancer stem‑like cell self‑renewal.
    Miao R, Huang D, Zhao K, Li Y, Zhang X, Cheng Y, Guo N., Free PMC Article

    03/27/2023
    Targeting HuR-Vav3 mRNA interaction prevents Pseudomonas aeruginosa adhesion to the cystic fibrosis airway epithelium.

    Targeting HuR-Vav3 mRNA interaction prevents Pseudomonas aeruginosa adhesion to the cystic fibrosis airway epithelium.
    Badaoui M, Sobolewski C, Luscher A, Bacchetta M, Köhler T, van Delden C, Foti M, Chanson M., Free PMC Article

    02/26/2023
    Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis.

    Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis.
    Nayak RC, Chang KH, Singh AK, Kotliar M, Desai M, Wellendorf AM, Wunderlich M, Bartram J, Mizukawa B, Cuadrado M, Dexheimer P, Barski A, Bustelo XR, Nassar NN, Cancelas JA., Free PMC Article

    06/11/2022
    The effect of VAV3 polymorphisms on thyroid cancer.

    The effect of VAV3 polymorphisms on thyroid cancer.
    Ren W, Xu C, Wang S, Li H, Dai H, Yang F, Shao Y, Bai Y.

    03/26/2022
    Vav3 Mediates Pseudomonas aeruginosa Adhesion to the Cystic Fibrosis Airway Epithelium.

    Vav3 Mediates Pseudomonas aeruginosa Adhesion to the Cystic Fibrosis Airway Epithelium.
    Badaoui M, Zoso A, Idris T, Bacchetta M, Simonin J, Lemeille S, Wehrle-Haller B, Chanson M.

    05/1/2021
    VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension.

    VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension.
    Miramontes-González JP, Usategui-Martín R, Martín-Vallejo J, Ziegler M, de Isla LL, O Connor D, González-Sarmiento R.

    02/20/2021
    Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression.

    Up-regulated LINC01234 promotes non-small-cell lung cancer cell metastasis by activating VAV3 and repressing BTG2 expression.
    Chen Z, Chen X, Lu B, Gu Y, Chen Q, Lei T, Nie F, Gu J, Huang J, Wei C, Sun M, Wang Z., Free PMC Article

    02/2/2021
    The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration.

    The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration.
    Ojala VK, Knittle AM, Kirjalainen P, Merilahti JAM, Kortesoja M, Tvorogov D, Vaparanta K, Lin S, Kast J, Pulliainen AT, Kurppa KJ, Elenius K., Free PMC Article

    01/23/2021
    Inactivation of Vav3 in vivo resulted in increased vascular leakage, highlighting its function as a key regulator of barrier stability.

    Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers.
    Hilfenhaus G, Nguyen DP, Freshman J, Prajapati D, Ma F, Song D, Ziyad S, Cuadrado M, Pellegrini M, Bustelo XR, Iruela-Arispe ML., Free PMC Article

    07/20/2019
    Vav3 in peripheral blood may serve as a biomarker for gastric cancer, and to predict the lymphatic metastasis in gastric cancer.

    The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
    Tan B, Li Y, Wang C, Tan M, Fan L, Zhao Q, Wang D, Jia N.

    06/29/2019
    The N-terminal truncated Vav3.1 may be decisively involved in mechanisms causing genuine multi-drug resistance.

    Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
    Reimer D, Boesch M, Wolf D, Marth C, Sopper S, Hatina J, Altevogt P, Parson W, Hackl H, Zeimet AG.

    11/3/2018
    VAV3 polymorphisms associate with cardiovascular risk factors and target organ damage.

    Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors.
    Perretta-Tejedor N, Fernández-Mateos J, García-Ortiz L, Gómez-Marcos MA, Recio-Rodríguez JI, Agudo-Conde C, Rodriguez-Sánchez E, Morales AI, López-Hernández FJ, López-Novoa JM, González-Sarmiento R, Martínez-Salgado C., Free PMC Article

    10/27/2018
    High VAV3 variant expression is associated with endometrial cancer.

    Evaluation of Vav3.1 as prognostic marker in endometrial cancer.
    Boesch M, Sopper S, Marth C, Fiegl H, Wiedemair A, Rössler J, Hatina J, Wolf D, Reimer D, Zeimet AG., Free PMC Article

    10/6/2018
    Results identified the diffuse B-cell lymphoma homology (DH) domain of Vav3 that interacts with the N-terminal region of AR-V7 (splice variants) and increases its expression in castration-resistant prostate cancer (CRPC). This interaction disrupted AR-V7 interaction with other AR coactivators like Src1 and Vav2.

    Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.
    Magani F, Peacock SO, Rice MA, Martinez MJ, Greene AM, Magani PS, Lyles R, Weitz JR, Burnstein KL., Free PMC Article

    06/16/2018
    We then explore the consequences of phorbol ester binding to a modified Vav3 in which the C1 domain has been altered to allow phorbol ester binding. We find both disruption of the guanyl nucleotide exchange activity of the modified Vav 3 as well as a shift in localization to the membrane upon phorbol ester treatment.

    The C1 domain of Vav3, a novel potential therapeutic target.
    Kelsey JS, Géczy T, Kaler CJ, Blumberg PM., Free PMC Article

    06/16/2018
    Overexpression of Vav3 is an independent risk factor for prognosis of gastric cancer, and can be used as a prognostic indicator.

    Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
    Tan B, Li Y, Shi X, Fan L, Zhao Q, Liu Y, Tan M, Liu Q, Jia N.

    04/21/2018
    Vav3 is a novel TRAF6 interaction partner that functions in the activation of cooperative signaling between T6BSs and the IVVY motif in the RANK signaling complex.

    Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.
    Yu J, Yun H, Shin B, Kim Y, Park ES, Choi S, Yu J, Amarasekara DS, Kim S, Inoue J, Walsh MC, Choi Y, Takami M, Rho J., Free PMC Article

    05/20/2017
    this study shows that the anti-tumor effects of astragaloside IV are mediated by the downregulation of Vav3-mediated Rac1/MAPK activation

    Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K, Lu Q, Li Q, Ji Y, Chen W, Xue X.

    04/15/2017
    Our results indicated that individuals carrying the VAV3 rs7528153 TT genotype were at a significantly increased risk of developing Paget's Disease of Bone

    VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone.
    Usategui-Martín R, Calero-Paniagua I, García-Aparicio J, Corral-Gudino L, Del Pino Montes J, González Sarmiento R., Free PMC Article

    04/8/2017
    Vav3 was accumulated in cell protrusions, contributed to the formation of membrane protrusions, and thereby increased the motility and invasiveness of pancreatic ductal adenocarcinoma cells

    Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.
    Tsuboi M, Taniuchi K, Furihata M, Naganuma S, Kimura M, Watanabe R, Shimizu T, Saito M, Dabanaka K, Hanazaki K, Saibara T.

    04/1/2017
    firstprevious page of 3 nextlast